• 한국항해항만학회:학술대회논문집
• /
• 한국항해항만학회 2000년도 추계학술대회논문집
• /
• pp.227-234
• /
• 2000

AGV is very proper equipment for Port Automation. AGV must have Obstacle Detection System(ODS) for port automation. Obstacle Detection System must have some functions. It must be able to classify some specified object from background data. And it must be able to track classified objects. Finally, ODS must determine its next action for safe cruise whether it must do emergency stop or it must speed down or it must change its track. For these functions, ODS can have many different structures. In this paper, we will propose one structure among some possible ones. Our ODS has been being developed using proposed structure since last year. In this paper, we will introduce our system which is under construction.

• 한국정밀공학회:학술대회논문집
• /
• 한국정밀공학회 1997년도 추계학술대회 논문집
• /
• pp.467-471
• /
• 1997

AGV is very proper equipment for Port Automation. AGV must have Obstacle Detection System(ODS) for port automation. Obstacle Detection System must have some functions. It must be able to classify some specified object from background data. And it must be able to track classified objects. Finally, ODS must determine its next action for safe cruise whether it must do emergency stop or it must speed down or it must change it track. For these functions, ODS can have many different structure. In this paper, we will propose one structure among some possible own which is under construction.

• 한국응용약물학회:학술대회논문집
• /
• 한국응용약물학회 2006년도 Proceedings of The Convention
• /
• pp.23-39
• /
• 2006

The application of the knowledge from the Human Genome Project to clinical medicine will be through both industrial drug development and the application of pharmacogenomics (PG) to patient care. The slow uptake of clinical innovations into clinical practice can be frustrating, but understanding the history of acceptance and sustaining medical innovation is critically important to position PG to succeed. This primarily means that PG tests must have legitimacy; they must be thoroughly validated, must be cost-effective, must be widely accepted by medical practitioners, must be supported by public policy, and must have a way of being easily incorporated into current medical practice. They must also lead to actionalble decisions by health care providers for their patients. Innovative PG assays should be tested in the best US laboratories, and reimbursement for testing must be accepted at the federal and state level. The companies providing these PG tests should be capable of supporting the interpretation and use of the test throughout medical practice. Advances such as the addition of PG information to drug labeling and the routine use of validated biomarkers to determine choice of cancer chemotherapy have been made. The PG research community must pay attention to the principles that have been previously described for acceptance and sustaining medical innovations in order for PG to be widely accepted in clinical medical practice.

• Biomolecules & Therapeutics
• /
• 제15권1호
• /
• pp.1-6
• /
• 2007

The application of the knowledge from the Human Genome Project to clinical medicine will be through both industrial drug development and the application of pharmacogenomics (PG) to patient care. The slow uptake of clinical innovations into clinical practice can be frustrating, but understanding the history of acceptance and sustaining medical innovation is critically important to position PG to succeed. This primarily means that PG tests must have legitimacy; they must be thoroughly validated, must be cost-effective, must be widely accepted by medical practitioners, must be supported by public policy, and must have a way of being easily incorporated into current medical practice. They must also lead to actionalble decisions by health care providers for their patients. Innovative PG assays should be tested in the best US laboratories, and reimbursement for testing must be accepted at the federal and state level. The companies providing these PG tests should be capable of sup-porting the interpretation and use of the test throughout medical practice. Advances such as the addition of PG information to drug labeling and the routine use of validated biomarkers to determine choice of cancer chemotherapy have been made. The PG research community must pay attention to the principles that have been previously described for acceptance and sustaining medical innovations in order for PG to be widely accepted in clinical medical practice.

• 한국약용작물학회:학술대회논문집
• /
• 한국약용작물학회 2006년도 Proceedings of The Convention of The Korean Society of Applied Pharmacology
• /
• pp.23-39
• /
• 2006

The application of the knowledge from the Human Genome Project to clinical medicine will be through both industrial drug development and the application of pharmacogenomics (PG) to patient care. The slow uptake of clinical innovations into clinical practice can be frustrating, but understanding the history of acceptance and sustaining medical innovation is critically important to position PG to succeed. This primarily means that PG tests must have legitimacy; they must be thoroughly validated, must be cost-effective, must be widely accepted by medical practitioners, must be supported by public policy, and must have a way of being easily incorporated into current medical practice. They must also lead to actionalble decisions by health care providers for their patients. Innovative PG assays should be tested in the best US laboratories, and reimbursement for testing must be accepted at the federal and state level. The companies providing these PG tests should be capable of supporting the interpretation and use of the test throughout medical practice. Advances such as the addition of PG information to drug labeling and the routine use of validated biomarkers to determine choice of cancer chemotherapy have been made. The PG research community must pay attention to the principles that have been previously described for acceptance and sustaining medical innovations in order for PG to be widely accepted in clinical medical practice.

• 한국운동역학회지
• /
• 제17권1호
• /
• pp.165-174
• /
• 2007

The subject of this study was male apparatus gymnastics athlete who had scored high points doing basket with 1/2 turn on parallel bars. Then 3D motion analysis were used to calculate & analyse kinematic variables of Basket with 1/2 turn to Handstand. 1. The total average time spent for Basket with 1/2 turn took $2.16{\pm}.08sec$, at the downward upward phase took $.58{\pm}0.00sec$, $.23{\pm}.00sec$, at flight phase took $.28{\pm}.01sec$, at connected area phase took $.72{\pm}0.21sec$, at rotation area phase took $.35{\pm}.14sec$. To have a successful performance, there should be faster speed and velocity to rotate at the downward upward phase, then the upward velocity and height must be used adequately. Moreover, the speed must be faster at the flight connect phase to stabilize Center of Mass(CM) for the body, and must secure more time at the rotation area to have more stable performance. 2. After handstand on parallel bars while moving CM to right hand side, and It must be performed with big and magnificent performance with putting both hand's center to far away from the parallel bars. 3. Furthermore, CM must be moved fast from downwards to right hand side, and CM must be moved fast in vertical movement at upward and flight phase to avoid CM from moving back and forth, and left and right. 4. At downwards, the subject must rotate as bis as possible using hip-joint as wide as possible and at upwards, must put his body to vertical to have stable performance. While rotating or turning, it is better to do with bigger shoulder angle and have to make sure that trunk angle must be not scattered. To perform better and more positive in basket with 1/2 turn on parallel bars, the centrifugal force must be used big and fast at downward, and at upward and flight phase, downward movement must change to vertical movement as soon as possible while turning movement must happen at handstand position. Time spent must be shorten at connected area to stabilize CM and turning must be natural as possible while securing the necessary time of movement to well-balanced. Also, the body must be vertically closed from the ground.

• Environmental Analysis Health and Toxicology
• /
• 제31권
• /
• pp.15.1-15.6
• /
• 2016

A number of absurdities surrounding the humidifier disinfectant (HD) incident may have occurred because 1) a judicial system operates on the underlying false assumption that the involved parties are equals in knowledge, information and resource mobilization capabilities, regardless of respective real status as company or individual; 2) there is a lack of a system that mandates a company to prevent and actively manage possible catastrophes; 3) the regulatory scheme makes companies believe that as long as they are complying with the existing regulations, they have satisfied all of their responsibilities. I believe that this issue is an opportunity to bring about changes in the judicial redress system, the system of internal management of manufacturers, and the regulatory system of the government. The following regulation amendments are needed to move towards the changes stated above. First, legislation relating to victim relief that is applicable to the HD incident must be established. Second, a risk management system must be formed within the manufacturing company and to this end an institutional environment for the system must be established within regulatory framework. Furthermore, legislation must be passed that could punish companies themselves that have caused severe damage to individuals because they had failed to take necessary actions to avoid foreseeable harm. Finally, the framework of regulation must be changed so that the company, who has the necessary information regarding the product and the component chemicals used in the product, must self-directed experiment and assessment of the safety of their own products.

• 의료법학
• /
• 제9권1호
• /
• pp.165-196
• /
• 2008

Recently the Supreme Court held that "in cases in which a patient suffering from a mental disorder attempts to commit suicide, fails, and then succeeds in a subsequent attempt, the following circumstances must be present in order to acknowledge reasonable causation between the negligence of the hospital with regards to taking care of the patient and the death of the patient; there must have existed negligence on the part of the hospital with regards to their failure to stop the 1stsuicide attempt, injurious aftereffects must have been caused to the patient by the1stsuicide attempt, and said aftereffects must have been the main cause for the 2nd successful suicide attemtp." This, in effect, lessens the requirements of past holdings of the Supreme Court which held that "to acknowledge reasonable causation between the negligence of the hospital and the patient that commits suicide, the patient must have experienced such severe physical and mental suffering from the previous attempt so that they could not help but choose to commit suicide". The fact that the Supreme Court did not clearly state such changes in their view on this matter should be corrected. Also, the fact that the court only held the hospital liable for damages of less than 50 million won, only calculating damages up to the point when the deceased passed, is inadequate compared to other cases and should be corrected.

• 산업경영시스템학회지
• /
• 제4권4호
• /
• pp.35-42
• /
• 1981

This paper grasped the labor productivity actual condition by the standard of per unit working hour and production about the main products of our country's industrial the main materials and could understand the average of our country's labor productivity as compared this with the labor productivity actual condition of Japan. As the point at issue of analitical result. 1. Low a matter of thinking about productivity. 2. Have a lot of difficult problem in an industrial part. 3. Have the point at issue on technical development and accumulation. 4. Have the point at issue on management. As a countermeasure about these. 1. must convert the way of use of industrial policy. 2. must make a housing development and special serialization of a small and medium enterprise. 3. must establish an organic technical development system. 4. must grope the policy of management rationalization.

• 제어로봇시스템학회:학술대회논문집
• /
• 제어로봇시스템학회 2002년도 ICCAS
• /
• pp.116.4-116
• /
• 2002

$\textbullet$In case of using overhead camera system, mobile robot moves under static working area. $\textbullet$Mobile robot must use onboard camera system to work under wide working area. $\textbullet$Mobile robot must have wireless LAN to remove restriction of movement. $\textbullet$Onboard camera system must have wireless LAN environment. $\textbullet$We develop embedded vision platform using onboard camera.